InsidersTradesSigma
Follow the 大正製薬ホールディングス株式会社 share price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares trade on the JP market, under the supervision of EDINET (Japan FSA). The latest transaction was filed on 29 January 2024 (Holding update). Among the most active insiders: Shoji Uehara. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
大正制药控股株式会社是一家日本公司，从事药品和保健产品的制造。该公司在东京证券交易所上市。